🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rasha Al‐Lamee

Imperial College Healthcare NHS Trust

ORCID: 0000-0003-3752-5532

Also affiliated with Hammersmith Hospital, Lung Institute, NIHR Imperial Biomedical Research Centre, Norwegian Womens Public Health Association, Imperial College London

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial”.

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

The Lancet(2024)10.1016/s0140-6736(24)00256-3
N/A
3.1DataRank · unranked
85 citations

Christopher Rajkumar, Fiyyaz Ahmed‐Jushuf, Florentina Simader, Shayna Chotai, Rachel Pathimagaraj +25 more

Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial

Circulation(2024)10.1161/circulationaha.124.069901
N/A
0.821DataRank · unranked
30 citations

Robin Young, George Abraham, Stephen P. Hoole, John P. Greenwood, Jayanth R. Arnold +26 more

Precision Pharmacotherapy With Zibotentan in Microvascular Angina: a randomized, placebo-controlled, cross-over trial.

Research Square(2023)10.21203/rs.3.rs-3714619/v1
N/A
0.104DataRank · unranked
1 citations

Andrew Morrow, George Abraham, Stephen P. Hoole, John P. Greenwood, Jayanth R. Arnold +23 more

Evolving Management Paradigm for Stable Ischemic Heart Disease Patients

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2022.08.814
N/A
0DataRank · unranked
68 citations

Mario Marzilli, Filippo Crea, G.B. John Mancini, William Weintraub, Viviany R. Taqueti +7 more